Related Experiment Video

Updated: Dec 23, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

COVID-19: Four Paediatric Cases in Malaysia

K C See1, S M Liew2, David C E Ng3

  • 1Department of Paediatric, Hospital Sungai Buloh, Ministry of Health, Malaysia.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|April 19, 2020
PubMed

Insights

Four pediatric COVID-19 cases in Malaysia presented with mild symptoms, highlighting challenges in child quarantine and testing accuracy. Clearer guidelines are needed for managing pediatric coronavirus disease 2019.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Epidemiology

Background:

  • Coronavirus disease 2019 (COVID-19) has rapidly spread globally.
  • Pediatric cases of COVID-19 are less common, necessitating specific reporting.
  • Understanding COVID-19 in children is crucial for disease management.

Purpose of the Study:

  • To report on pediatric cases of COVID-19 in Malaysia.
  • To highlight challenges in managing COVID-19 in children.

Main Methods:

  • Retrospective review of four pediatric COVID-19 cases in Malaysia (up to February 2020).
  • Cases involved children aged 20 months to 11 years, likely infected in China.
  • Clinical presentation and management were documented.

Main Results:

  • All four pediatric cases exhibited no symptoms or mild flu-like illness.
  • Symptomatic management was provided; no antiviral therapy was required.
  • Two key issues identified: ethical dilemma in quarantining infected children with negative-testing parents and risk of false-negative swab results.

Conclusions:

  • Ethical considerations for quarantine policies in pediatric COVID-19 cases require attention.
  • Diagnostic challenges, including false-negative results from oropharyngeal and nasal swabs in children, need addressing.
  • Development of clearer guidelines for pediatric quarantine and testing is essential for effective infection control in COVID-19 management.
Abstract

Keywords:
COVID-19CoronavirusEpidemiologyOutbreakPaediatricepidemicnCoV

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
133
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
149
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Pareto Chart00:52

Pareto Chart

A Pareto chart is a bar graph or a combination of both line and bar graphs. The bar lengths represent the individual values or the frequency, while the lines represent the cumulative total values. In this chart, the longest bars are arranged on the left and the shortest bars on the right, which makes it easier to read and interpret the data. It can also be called a Pareto diagram or Pareto analysis.
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
7.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K